NEW YORK, United States, Sept. 17, 2022 (GLOBE NEWSWIRE) — Facts and Factors has released a new research report titled In vitro fertilization (IVF) market by type (conventional IVF, IVF with ICSI, IVF with Donarei, others), by cycle (fresh IVF cycles without donor, frozen IVF cycles without donor, frozen IVF cycles without donor donors, fresh donors IVF cycle), by product (devices, sperm analysis systems, imaging systems, ovum aspiration pumps, micromanipulator systems, incubators, gas analyzers, laser systems, cryosystems, sperm separators, IVF cabinets, anti-vibration tables, witness systems, other devices, reagents and media, media for cryopreservation, media for embryo culture, media for oocyte processing, media for sperm processing, accessories), by end-user (fertility clinics, hospitals and surgical centers, cryobanks, research institutes) and by region – global and regional industry overview, market intelligence, comprehensive analysis , historical data and forecasts 2022–2028” in its research database.
“The globe In vitro fertilization (IVF) market. was worth approximately $628.50 million in 2021 and is projected to grow to approximately $1,036.7 million by 2028 at a compound annual growth rate (CAGR) of approximately 8.7% over the forecast period.”
The report analyzes the drivers, restraints/challenges of the In Vitro Fertilization (IVF) market and the impact they are having on the demand during the projection period. Additionally, the report examines emerging trends and opportunities in the In Vitro Fertilization (IVF) market.
IVF Industry Summary:
In vitro fertilization (IVF) enables the use of reproductive technology in real life, helping couples to conceive children with complications naturally. The increasing sedentary lifestyle and bad habits have led to an increase in impotence and other fertility problems around the world, thereby fueling the demand for in vitro fertilization (IVF), which is advanced fertility clinics that are capable to treat reproductive problems.
Increasing popularity of in vitro fertilization (IVF), increasing availability of in vitro fertilization (IVF) procedures, and increasing healthcare spending are expected to be prominent trends driving the growth of in vitro fertilization (IVF) market in global Forecast period will advance. However, the high costs associated with these procedures are holding back the growth of the in vitro fertilization (IVF) market.
Click here to access Free Sample Report of Global In Vitro Fertilization (IVF) Market @ https://www.fnfresearch.com/sample/in-vitro-fertilization-market
growth driver of the industry
Growth in the mean age of primiparous women
The increasing development of the human population has pushed the average age of primiparae to a considerably high number, as more women prefer late marriages and, contrary to previous trends, choose careers over family planning. The effective use of contraceptives has also played a crucial role in shaping the mean age of primiparous women and this is expected to significantly drive the growth of the In Vitro Fertilization (IVF) market during the forecast period.
High cost of in vitro fertilization (IVF) procedures
In vitro fertilization (IVF) procedures are known to be costly around the world and this is the main factor that will hamper the in vitro fertilization (IVF) market potential during the forecast period. The lack of insurance coverage exacerbates this situation in countries where healthcare is expensive, and irregularities in the reimbursement of these procedures also hamper the growth of the overall in vitro fertilization (IVF) market.
Directly buy a copy of the report with TOC @ https://www.fnfresearch.com/buynow/su/in-vitro-fertilization-market
The global in vitro fertilization (IVF) market is segmented by type, cycle, product, end-use and region.
The in vitro fertilization (IVF) market is segmented by end-user into fertility clinics, hospitals and surgical centers, cryobanks, and research institutes. The fertility clinics segment will have good forecast prospects as governments around the world focus on establishing these clinics to ensure public health and fertility awareness and boost birth rate.
The global in vitro fertilization (IVF) market is segmented as follows:
- Conventional IVF
- IVF with ICSI
- IVF with Donar Egg
- Fresh donor-less IVF cycles
- Frozen donorless IVF cycles
- Frozen Donor IVF Cycles
- Fresh donor IVF cycle
- sperm analysis systems
- imaging systems
- Ovum Aspiration Pumps
- micromanipulator systems
- gas analyzers
- laser systems
- cryogenic systems
- Sperm Separation Devices
- IVF cabinets
- anti-vibration tables
- witness systems
- other equipment
- Reagents & Media
- cryopreservation media
- Embryo Culture Media
- Ovum Processing Media
- sperm processing media
By end users
- fertility clinics
- Hospitals and Surgical Centers
- research institutes
Search fully “In Vitro Fertilization (IVF) Market – Global & Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data and Forecast 2022-2028” report below https://www.fnfresearch.com/in-vitro-fertilization-market
Some of the major competitors dominating the global in vitro fertilization (IVF) market are –
The Cooper Companies Inc. (USA), Cook Group (USA), Vitrolife (Sweden), Thermo Fisher Scientific, Inc. (USA), Esco Micro Pte. ltd (Singapore), Genea Limited (Australia), IVFtech ApS (Denmark), FUJIFILM Irvine Scientific (USA), The Baker Company, Inc. (USA), Kitazato Corporation (Japan), Rocket Medical plc (UK), Hamilton Thorne Ltd. (USA), ZEISS Group (Germany), FERTIPRO NV (Belgium) and Gynotec BV (Netherlands).
Key findings from primary research:
- According to the analysis, the In Vitro Fertilization (IVF) market is expected to grow at a CAGR of around 8.7% over the period 2022-2028.
- In terms of revenue, the In Vitro Fertilization (IVF) market size was estimated at around US$628.50 million in 2021 and is expected to reach US$1,036.7 million by 2028.
- Favorable prospects are expected for the fertility clinics segment in the planned period.
- The fresh non-donor segment is expected to account for a large market share and is projected to be a dominant segment during the forecast period.
- In the Asia-Pacific region, the in vitro fertilization (IVF) market is expected to experience dominant prospects over the projected period.
Request to customize this report according to your needs – https://www.fnfresearch.com/customization/in-vitro-fertilization-market
The Asia Pacific region is expected to be the most lucrative market for the in vitro fertilization (IVF) industry and this trend is expected to be driven by several factors. Increasing availability and popularity of in vitro fertilization (IVF) procedures and increasing preference of couples for such procedures will be the key trends impelling the growth of in vitro fertilization (IVF) market in this region during the forecast period . India and China are expected to lead the growth curve in this region by 2028. Increasing medical tourism, increasing number of in vitro fertilization (IVF) centers, increasing focus on fertility, increasing adoption of reproductive technology, and rising healthcare spending are other key trends expected to drive the growth of in vitro fertilization (IVF) market over the forecast period will affect.
- North America
- Rest of North America
- United Kingdom
- rest of Europe
- Asia Pacific
- South Korea
- Rest of Asia Pacific
- The Middle East & Africa
- Saudi Arabia
- South Africa
- Rest of Middle East and Africa
- Latin America
- Rest of Latin America
In 2021 – CooperSurgical and Virtus Health announced the launch of a new partnership aimed at strengthening their fertility technology and increasing access to infertile couples around the world.
|Market size (2021)||$628.50 million|
|Future market size (2028)||$1,036.7 million|
|CAGR Growth Rate (%)||8.7% CAGR|
|Prominent Vendors||The Cooper Companies Inc. (USA), Cook Group (USA), Vitrolife (Sweden), Thermo Fisher Scientific, Inc. (USA), Esco Micro Pte. ltd (Singapore), Genea Limited (Australia), IVFtechApS (Denmark), FUJIFILM Irvine Scientific (USA), The Baker Company, Inc. (USA), Kitazato Corporation (Japan), Rocket Medical plc (UK), Hamilton Thorne Ltd (USA ), ZEISS Group (Germany), FERTIPRO NV (Belgium) and Gynotec BV (Netherlands), among others|
|main segment||By type, cycle, product, end user and region|
|key regions||North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa|
Browse other related research reports by Facts & Factors:
Global protein expression market Stock expected to grow at a CAGR of 12.70% through 2028: https://www.fnfresearch.com/protein-expression-market
Global Donor Egg IVF Services Market Stock expected to grow at a CAGR of 24.10% through 2028: https://www.fnfresearch.com/donor-egg-ivf-services-market
Global Telemedicine Market for Female Reproductive & Sexual Health The stock is expected to grow at a CAGR of 16.20% through 2028: https://www.fnfresearch.com/telehealth-for-womens-reproductive-and-sexual-health-market
Global Medical Transportation Services Market expected to grow at a CAGR of 4.50% through 2028: https://www.fnfresearch.com/medical-transport-services-market
Global Neuroscience Market expected to grow at a CAGR of 3.50% through 2028: https://www.fnfresearch.com/neuroscience-market
Global market share of clinical decision support systems expected to grow at a CAGR of around 11.9% through 2028: https://www.fnfresearch.com/clinical-decision-support-system-market
About Facts & Factors:
Facts & Factors is a leading market research firm providing clients with industry expertise and conscientious business development consulting services. The reports and services offered by Facts and Factors are used worldwide by renowned academic institutions, start-ups and companies to measure and understand the changing international and regional business backgrounds.
Facts & Factors
UNITED STATES OF AMERICA: +1 347 690-0211 | UNITED KINGDOM: +44 2032 894158 | Japan: +81 50 5806 9039 | India: +91 73877 19999
E-mail: email@example.com | Network: https://www.fnfresearch.com
Follow us on – LinkedIn | Twitter | Facebook